Načítá se...
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
BACKGROUND: Tamoxifen and raloxifene reduce the risk of breast cancer in women at elevated risk of disease, but the duration of the effect is unknown. We assessed the effectiveness of selective oestrogen receptor modulators (SERMs) on breast cancer incidence. METHODS: We did a meta-analysis with ind...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Lancet Publishing Group
2013
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3671272/ https://ncbi.nlm.nih.gov/pubmed/23639488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(13)60140-3 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|